PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling